How Effective, Safe is Mosunetuzumab/Polatuzumab Vedotin in Pretreated MCL?
Results from a phase 2 trial (NCT03671018) that evaluated mosunetuzumab-axgb (Lunsumio) plus polatuzumab vedotin-piiq (Polivy) showed that, in all patients...
Results from a phase 2 trial (NCT03671018) that evaluated mosunetuzumab-axgb (Lunsumio) plus polatuzumab vedotin-piiq (Polivy) showed that, in all patients...